Our partner is focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. Their approach aims to deliver potent therapies directly to tumors, improving treatment efficacy while minimizing side effects, with the goal of enhancing patient outcomes in oncology.

This Physician drove high-profile clinical programs as our partner continued to expand their lead program with 4 different arms in both NSCL and Ovarian Cancer patients. This hire helped create clinical development strategy by shaping how the company perceived and operationalized clinical studies. They built and executed clinical development plans including design, implementation, analysis, and reporting of clinical studies. This hire also collaborated with the program team in developing long-range strategic plans for programs and worked closely with cross functional teams.